Pomerantz LLP is investigating Scholastic Corporation for potential securities fraud following the company's Q1 fiscal 2027 report, which showed an adjusted loss of $3.63 per share, missing estimates, and a 4% revenue decline to $216.8 million. The Education segment revenue fell 24% due to tighter school budgets, causing Scholastic's stock to drop 7.41% on September 25, 2026. The investigation aims to determine if Scholastic and its executives engaged in unlawful business practices. This legal action could impact investor confidence and the company's future disclosures.
The story concerns Scholastic Corporation and its recent financial and legal challenges. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Oct 14, 2026 03:41 WIB: out of 126 priced US stocks, 82 rose and 43 fell. Notable movers include TDUP at USD 2.33 with a 6.05% decline and 100% buy order activity, PRTS at USD 8.22 down 5.19% with 100% sell order activity, and DPZ at USD 295.80 down 4.86% with nearly balanced buy/sell activity.
Applied Materials projects sustained demand for its chipmaking equipment driven by AI infrastructure growth, expecting faster spending on wafer fab equipment through 2030. The company aims to increase its market share by over 2 percentage points from...
Gordon Haskett Capital Corporation set a $105 price target for Ollie's Bargain Outlet, suggesting an 18.1% upside from its current price around $89. The company’s board approved an additional $500 million share repurchase authorization, increasing to...
FRUIT Holdings, Inc. introduced PAVE, a new protocol designed to allow AI systems to call on human judgment and authority when needed. This approach ensures that human input retains its value, authority, and attribution within AI workflows, addressin...
AngioDynamics reported a 6.9% revenue increase to $80.9 million and a narrowed adjusted loss of 4 cents per share for Q1 fiscal 2027, with strong Med Tech sales growing 13.2%. Despite beating earnings expectations and improved gross margin, the stock...
Pomerantz LLP is investigating Cellebrite DI Ltd. for potential securities fraud following the company's Q2 2026 financial report, which showed Annual Recurring Revenue (ARR) below guidance and a lowered full-year ARR forecast. The company also abrup...
